Fig. 1From: The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetesStages of clinical trial progress. ELISA enzyme-linked immunosorbent assay, FBS fasting blood sugar, HOMA-IR homeostatic model assessment of insulin resistance, hs-CRP high-sensitivity C-reactive protein, MDA malondialdehyde, TAC total antioxidant capacityBack to article page